Dashboard
Manage Tickers

EVAXEvaxion Biotech A/S

Nasdaq evaxion-biotech.com


$ 2.79 $ 0.03 (1.05 %)    

Friday, 28-Jun-2024 10:35:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 2.9
$ 2.79
$ 0.00 x 0
$ 0.00 x 0
$ 2.79 - $ 2.79
$ 2.26 - $ 13.82
8,544
na
109.9M
$ 1.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evaxion-on-patent-application-for-ai-based-novel-cancer-vaccine-target-identification-method-says-an-international-preliminary-report-on-patentability-indicates-promising-prospects-for-obtaining-granted-patents-and-protecting-the-invention
Evaxion, On Patent Application for AI-Base...
06/26/2024 11:31:59

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/19/2024 20:30:52

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

evaxion-announces-publication-of-data-from-phase-1-dose-escalation-study-of-evx-01-in-journal-for-immunotherapy-of-cancer--demonstrating-67-objective-response-rate
Evaxion Announces Publication Of Data From...
06/17/2024 12:46:33

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
06/04/2024 11:17:30

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

evaxion-presents-validating-immune-data-from-ongoing-phase-2-trial-with-ai-designed-evx-01-vaccine-at-the-asco-annual-meeting-2024
Evaxion Presents Validating Immune Data Fr...
06/03/2024 12:47:34

Evaxion's AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melan...

evaxion-biotech-q1-eps-003-beats-056-estimate-sales-5100k-beat-3700k-estimate
Evaxion Biotech Q1 EPS $0.03 Beats $(0.56)...
05/28/2024 12:30:00

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.5...

evaxion-received-a-letter-from-the-nasdaq-listing-qualifications-department-notifying-that-it-is-not-currently-in-compliance-with-the-minimum-stockholders-equity-requirement
Evaxion Received A Letter From The Nasdaq ...
05/10/2024 21:03:50

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

evaxion-biotech-files-for-for-offer-and-sale-of-up-to-1945m-ordinary-shares-represented-by-1945m-adss-by-selling-shareholders
Evaxion Biotech Files For For Offer And Sa...
05/06/2024 21:12:04

evaxion-announces-first-patient-completed-dosing-with-personalized-cancer-vaccine-evx-01
Evaxion Announces First Patient Completed ...
04/17/2024 12:09:57

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
04/03/2024 10:41:18

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 16:31:06

ladenburg-thalmann-upgrades-evaxion-biotech-to-buy-announces-8-price-target
Ladenburg Thalmann Upgrades Evaxion Biotec...
04/02/2024 15:39:13

Ladenburg Thalmann analyst Ahu Demir upgrades Evaxion Biotech (NASDAQ:EVAX) from Neutral to Buy and announces $8 price target.

evaxion-biotech-concludes-large-non-rodent-animal-infection-studies-testing-antigens-from-evaxions-preclinical-evx-b1-vaccine-candidate-against-staphylococcus-aureus-studies-showed-evx-b1-antigens-significantly-reduced-disease-burden
Evaxion Biotech Concludes Large Non-rodent...
04/02/2024 11:08:37

recap-evaxion-biotech-q4-earnings
Recap: Evaxion Biotech Q4 Earnings
03/27/2024 13:35:07

evaxions-2023-cash-and-cash-equivalents-of-56m-and-capital-raise-of-127m-is-expected-to-provide-cash-runway-into-april-2025
Evaxion's 2023 Cash And Cash Equivalents O...
03/27/2024 11:36:35

evaxion-biotech-q4-eps-016-beats-160-estimate-sales-7300k
Evaxion Biotech Q4 EPS $(0.16) Beats $(1.6...
03/27/2024 11:34:12

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(1.6...

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
03/20/2024 10:54:33

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Core News & Articles
Evaxion Announces Completion of the Initia...
02/20/2024 12:32:47

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)